Parallel phase 1 clinical trials inthe US andin China:accelerating the test ofavitinib inlung cancer asa novel inhibitor selectively targeting mutated EGFR andovercoming T790M-induced resistance
growth factor receptor、the United States、targeted therapy、clinical trials、cancer patients
R73;TU5
2015-08-20(万方平台首次上网日期,不代表论文的发表时间)
共3页
285-287